Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review

Xeroderma Pigmentosum (XP) is a rare genetic disorder with a poor prognosis due to high photosensitivity in affected patients. Herein, we describe the first case of the use of cemiplimab in a patient with XP, a 19-year-old girl presented with locally advanced squamous cell carcinoma of the right per...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubatto, Marco, Merli, Martina, Avallone, Gianluca, Agostini, Andrea, Mastorino, Luca, Caliendo, Virginia, Barcellini, Amelia, Vitolo, Viviana, Valvo, Francesca, Fierro, Maria Teresa, Ribero, Simone, Quaglino, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169062/
https://www.ncbi.nlm.nih.gov/pubmed/34084285
http://dx.doi.org/10.18632/oncotarget.27966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169062/
https://www.ncbi.nlm.nih.gov/pubmed/34084285
http://dx.doi.org/10.18632/oncotarget.27966

Ejemplares similares